These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 11234909)

  • 41. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.
    Gibbie T; Mijch A; Ellen S; Hoy J; Hutchison C; Wright E; Chua P; Judd F
    HIV Med; 2006 Mar; 7(2):112-21. PubMed ID: 16420256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A comparison of neurocognitive impairment in younger and older adults with major depression.
    Thomas AJ; Gallagher P; Robinson LJ; Porter RJ; Young AH; Ferrier IN; O'Brien JT
    Psychol Med; 2009 May; 39(5):725-33. PubMed ID: 18667097
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cognitive impairment in unipolar depression is persistent and non-specific: further evidence for the final common pathway disorder hypothesis.
    Reppermund S; Ising M; Lucae S; Zihl J
    Psychol Med; 2009 Apr; 39(4):603-14. PubMed ID: 18667101
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
    Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
    J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mismatch negativity analysis in drug-resistant epileptic patients implanted with vagus nerve stimulator.
    Borghetti D; Pizzanelli C; Maritato P; Fabbrini M; Jensen S; Iudice A; Murri L; Sartucci F
    Brain Res Bull; 2007 Jun; 73(1-3):81-5. PubMed ID: 17499640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropsychological deficits in adolescent unipolar depression.
    Klimkeit EI; Tonge B; Bradshaw JL; Melvin GA; Gould K
    Arch Clin Neuropsychol; 2011 Nov; 26(7):662-76. PubMed ID: 21690097
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Changes in gustatory perceptions of patients with major depression treated with vagus nerve stimulation (VNS).
    Sperling W; Biermann T; Spannenberger R; Clepce M; Padberg F; Reulbach U; Kornhuber J; Thuerauf N
    Pharmacopsychiatry; 2011 Mar; 44(2):67-71. PubMed ID: 21157695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neurocognitive profiles of people with comorbid depression and alcohol use: implications for psychological interventions.
    Hunt SA; Baker AL; Michie PT; Kavanagh DJ
    Addict Behav; 2009 Oct; 34(10):878-86. PubMed ID: 19398163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuropsychological safety of nucleus accumbens deep brain stimulation for major depression: effects of 12-month stimulation.
    Grubert C; Hurlemann R; Bewernick BH; Kayser S; Hadrysiewicz B; Axmacher N; Sturm V; Schlaepfer TE
    World J Biol Psychiatry; 2011 Oct; 12(7):516-27. PubMed ID: 21736514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. No evidence for cognitive side effects after 6 months of vagus nerve stimulation in epilepsy patients.
    Hoppe C; Helmstaedter C; Scherrmann J; Elger CE
    Epilepsy Behav; 2001 Aug; 2(4):351-6. PubMed ID: 12609212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term Sustained Cognitive Benefits of Vagus Nerve Stimulation in Refractory Depression.
    Desbeaumes Jodoin V; Richer F; Miron JP; Fournier-Gosselin MP; Lespérance P
    J ECT; 2018 Dec; 34(4):283-290. PubMed ID: 29870432
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Other treatments for depressive patients].
    Tamaoki T; Motohashi N
    Nihon Rinsho; 2007 Sep; 65(9):1655-9. PubMed ID: 17876990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A longitudinal analysis of neurocognitive function in unipolar depression.
    Biringer E; Mykletun A; Sundet K; Kroken R; Stordal KI; Lund A
    J Clin Exp Neuropsychol; 2007 Nov; 29(8):879-91. PubMed ID: 17852600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vagus nerve stimulation in therapy of depression--description of the method and some critical remarks].
    Zyss T
    Psychiatr Pol; 2010; 44(1):71-88. PubMed ID: 20449982
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identifying cognitive problems in children and adolescents with depression using computerized neuropsychological testing.
    Brooks BL; Iverson GL; Sherman EM; Roberge MC
    Appl Neuropsychol; 2010 Jan; 17(1):37-43. PubMed ID: 20146120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vagus nerve stimulation: mood and cognitive effects.
    Schachter SC
    Epilepsy Behav; 2004 Feb; 5 Suppl 1():S56-9. PubMed ID: 14725847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral blood flow during vagus nerve stimulation--a transcranial Doppler study.
    Neu P; Heuser I; Bajbouj M
    Neuropsychobiology; 2005; 51(4):265-8. PubMed ID: 15905632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vagus nerve stimulation (VNS) for major depressive episodes: one year outcomes.
    Marangell LB; Rush AJ; George MS; Sackeim HA; Johnson CR; Husain MM; Nahas Z; Lisanby SH
    Biol Psychiatry; 2002 Feb; 51(4):280-7. PubMed ID: 11958778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Motor cortex excitability after vagus nerve stimulation in major depression.
    Bajbouj M; Gallinat J; Lang UE; Hellen F; Vesper J; Lisanby SH; Danker-Hopfe H; Neu P
    J Clin Psychopharmacol; 2007 Apr; 27(2):156-9. PubMed ID: 17414238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.